MarketBeatTue, 09 Jun 2026 09:02:22 GMTCorbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts NearCRBP-3.37%
Seeking AlphaMon, 01 Jun 2026 17:34:04 GMTCorbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Key Insights from HNSCC KOL Event TranscriptCRBP-3.37%
MarketBeatMon, 01 Jun 2026 14:05:21 GMTCorbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 StudyCRBP-3.37%
Seeking AlphaTue, 26 May 2026 17:37:06 GMTCorbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO TranscriptCRBP-3.37%
MarketBeatFri, 22 May 2026 07:05:33 GMTCorbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity ReadoutCRBP-3.37%
BenzingaTue, 07 Apr 2026 15:56:22 GMTCorbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive EdgeCRBP-3.37%
